UCA1 has been implicated in the oncogenic function of CCAAT/enhancer-binding protein-ex dominant-negative isoform (C/EBPcx-p30)-positive AMLs [250] and in the chemoresistance of AML cells to daunorubicin-based therapeutics [251]. The gene discussed is UCA1; the disease is acute myeloid leukemia.